Researchers engineer novel disease model to identify potential targets for ulcerative colitis drugs
Physician-pharmacist collaboration may increase adherence to opioid addiction treatment
11 January 2021A new, potent weapon against lymphomas
11 January 2021Researchers engineer novel disease model to identify potential targets for ulcerative colitis drugs
As reported in Nature Communications, researchers from Cleveland Clinic’s Lerner Research Institute have developed a novel, patient-derived model of ulcerative colitis, which will help advance studies into new treatments for the chronic inflammatory bowel disease.
